KLF9 and non-Hodgkin lymphoma: By qMSP we analyzed the promoter methylation status of KLF9, MTSS1, NR4A2, KCNH2, DSP, FZD8, and PPP1R14A in 37 NHL patients and CD19+-B-cells from 10 healthy donors.